Compounds > n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea
Page last updated: 2024-09-03

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Kidney Neoplasms

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea has been researched along with Kidney Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adenis, A; Chauvergne, J; Chollet, P; Dieras, V; Fargeot, P; Kerbrat, P; Lentz, MA; Madelmont, JC; Pujade-Lauraine, E; Toulouse, C1

Trials

1 trial(s) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Kidney Neoplasms

ArticleYear
Phase II study of cystemustine in advanced renal cancer.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:1

    Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Nitrosourea Compounds

1995